Effect of a New Oral Contraceptive Pill on Hormone Related Symptoms Such as Pelvic Pain and Headache
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to investigate whether women taking a new combined oral
contraceptive pill (SH T00658ID, estradiol valerate/dienogest) experience fewer hormone
withdrawal-associated symptoms such as pelvic pain or headache during their monthly cycle
compared to a commonly used contraceptive pill (Microgynon).